Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) Other Operating Expenses: 2014-2025

Historic Other Operating Expenses for Fortress Biotech (FBIO) over the last 11 years, with Sep 2025 value amounting to $6.8 million.

  • Fortress Biotech's Other Operating Expenses rose 29.03% to $6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.1 million, marking a year-over-year decrease of 33.35%. This contributed to the annual value of $23.7 million for FY2024, which is 30.57% down from last year.
  • As of Q3 2025, Fortress Biotech's Other Operating Expenses stood at $6.8 million, which was up 13.59% from $6.0 million recorded in Q2 2025.
  • Over the past 5 years, Fortress Biotech's Other Operating Expenses peaked at $20.7 million during Q3 2021, and registered a low of $1.4 million during Q3 2023.
  • Over the past 3 years, Fortress Biotech's median Other Operating Expenses value was $6.4 million (recorded in 2023), while the average stood at $6.5 million.
  • Per our database at Business Quant, Fortress Biotech's Other Operating Expenses skyrocketed by 512.81% in 2021 and then slumped by 80.61% in 2023.
  • Fortress Biotech's Other Operating Expenses (Quarterly) stood at $9.5 million in 2021, then dropped by 18.97% to $7.7 million in 2022, then surged by 33.96% to $10.3 million in 2023, then tumbled by 76.76% to $2.4 million in 2024, then rose by 29.03% to $6.8 million in 2025.
  • Its last three reported values are $6.8 million in Q3 2025, $6.0 million for Q2 2025, and $5.9 million during Q1 2025.